High Tower Advisors, LLC Tyme Technologies, Inc. Call Options Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

Call Options

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2021 Aug 06, 2021	BUY	$1.14 - $1.87 $36,181 - $59,350	31,738 Added 12113.74%	32,000 $14,000
Q4 2020 Feb 10, 2021	SELL	$0.87 - $1.26 $10,908 - $15,797	-12,538 Reduced 97.95%	262 $17,000
Q3 2020 Nov 13, 2020	SELL	$0.93 - $1.35 $15,066 - $21,870	-16,200 Reduced 55.86%	12,800 $3,000
Q2 2020 Aug 10, 2020	BUY	$0.97 - $1.7 $6,596 - $11,560	6,800 Added 30.63%	29,000 $10,000
Q1 2020 May 21, 2020	SELL	$0.9 - $1.95 $10,170 - $22,035	-11,300 Reduced 33.73%	22,200 $4,000
Q4 2019 Feb 14, 2020	BUY	$1.0 - $1.49 $22,500 - $33,525	22,500 Added 204.55%	33,500 $13,000
Q3 2019 Nov 12, 2019	BUY	$0.97 - $1.77 $10,670 - $19,470	11,000 New	11,000 $4,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.